Skip to main content
Clinical Trials/CTRI/2021/09/036746
CTRI/2021/09/036746Not yet recruitingPhase 2

Clinical evaluation of desensitising agent[ Pro arginine Tm] and diode laser 475nm [Blue lase Tm] in providing instant sustenance in the treatment of dentinal hypersensitivity: a split mouth randomized trial

V Sailatha0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients in good systemic health with clinically elicitable dentin hypersensitivity who were reliable in their response to test measurements
  • Who were not treated earlier for DH were included in the study

Exclusion Criteria

  • Patients with any systemic conditions
  • Those who were on any analgesics/antiâ??inflammatory drugs at the time of the study
  • Those who had used any desensitizing paste or mouthwash during the last 6 months.

Investigators

Sponsor
V Sailatha

Similar Trials

Treatment of hypersensitivity using... | Clinical Trial